Society for Investigative Dermatology | Dermatology Research | Academic Dermatology
This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Other Opportunities
Share |


National Psoriasis Foundation: To further the mission ā€œto find a cure for psoriatic disease and improve the lives of those affectedā€, the National Psoriasis Foundation (NPF) is pleased to announce the dedication of $3.3 million across 9 different programs to support psoriatic disease research this coming year. NPF encourages applications from all facets of psoriatic disease and related comorbidities research, including basic science, translational & clinicaresearch, technology, epidemiology & public health.  Find more information on opportunities and deadlines here.



The Cutaneous Lymphoma Foundation The Cutaneous Lymphoma Foundation is pleased to announce that it is accepting applications for its Young Investigator Award, which supports travel to the 2020 World Congress of Cutaneous Lymphomas (WCCL) to be held February 12-14, 2020 in Barcelona, Spain. More info here


PeDRA Awards: Established in 2012 as the first-ever research alliance in pediatric dermatology, PeDRA is a vibrant organization focused on conducting high quality research to improve the lives of children and their families. This year, PeDRA is offering funding to support studies, investigators, and high priority initiatives through various programs. More information here


Society for Investigative Dermatology
526 Superior Avenue East, Suite 340
Cleveland, Ohio 4411

Tel: 216.579.9300
Fax: 216.579.9333

The SID mission is to advance the sciences relevant to skin disease through education,

advocacy and scholarly exchange of scientific information.